The Focused Ultrasound Foundation Seminar Series presents Dr. Rosie Xing, renowned cancer biologist and translational research leader at Chongqing Medical University and managing director at Chongqing Haifu Medical Technology. Dr. Xing shares her compelling journey from drug development at Sloan Kettering to pioneering noninvasive therapies using focused ultrasound (FUS). In this presentation, Dr. Xing outlines how Chongqing Haifu has treated over 300,000 patients worldwide, including thousands with malignant tumors, and is now collaborating with UVA to launch a new FUS center. In this seminar, you’ll discover: • How focused ultrasound can overcome tumor heterogeneity and treatment resistance • Clinical applications of FUS in liver, pancreatic, breast, and bone cancers • Breakthrough outcomes in uterine fibroids and adenomyosis, including fertility preservation • Real-world data on FUS safety, effectiveness, and global adoption • Innovations in AI-enabled treatment planning, real-time monitoring, and histotripsy integration • A vision for combining FUS with chemotherapy and immunotherapy to enhance cancer outcomes Dr. Xing also presents remarkable international case studies, including long-term survival, pain relief, and fertility success stories. This talk underscores the transformative potential of focused ultrasound as a precise, patient-centered approach to both oncologic and gynecologic care. Learn how FUS is becoming a global standard treatment option merging technological innovation, rigorous research, and compassionate medicine.

Original link: https://www.youtube.com/watch?v=gQpPbuwLn8s